Search

Your search keyword '"Long term response"' showing total 17 results

Search Constraints

Start Over You searched for: Descriptor "Long term response" Remove constraint Descriptor: "Long term response" Journal journal of clinical oncology Remove constraint Journal: journal of clinical oncology
17 results on '"Long term response"'

Search Results

1. Molecular determinants associated with long-term response to apalutamide (APA) in nonmetastatic castration-resistant prostate cancer (nmCRPC)

2. Clinical predictors of long-term response to capecitabine in metastatic breast cancer (MBC)

Catalog

Books, media, physical & digital resources

3. Vascular endothelial growth factor A (VEGF-A) amplification and long-term response to ramucirumab (ram) in metastatic gastric cancer (mGC): The VERA study

4. KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the Literature

5. Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC

6. Cell free (cf) DNA as a tumor marker in transitional cell cancer (TCC): Monitoring response to checkpoint inhibitor (CPI) therapy

7. Molecular predictors of long-term response to crizotinib in ALK+ advanced non-small cell lung cancer (NSCLC) patients

8. Retrospective analysis of patients (pts) with metastatic melanoma (MM) showing long-term response (LTR) to vemurafenib (Vb)

9. Long-term response and time to response to pazopanib (PAZ) and sunitinib (SUN) in metastatic renal cell carcinoma (mRCC): COMPARZ subanalysis

10. Integrated analysis of mRNA and miRNA to unravel novel mechanisms of sunitinib long term response in mRCC

11. Long-term response to sunitinib treatment in metastatic renal cell carcinoma (mRCC)

12. Long-term response in metastatic renal cell carcinoma patients receiving first-line therapy with VEGF TKIs

14. Long-term response in a patient with urothelial cancer (UC) treated with AEZS-108

15. Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC)

16. Characteristics of sarcoma patients with long-term response to gemcitabine and paclitaxel

17. Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center